Abstract
Ciprofloxacin is a new quinolone carboxylic acid derivative with antibacterial activity against a broad spectrum of gram-positive and gram-negative bacteria causing nosocomial urinary tract infections. It can be given by either the oral or the parenteral route (1). The purpose of this study was to evaluate the serum and tissue pharmacokinetics of ciprofloxacin after i.v. administration at various times prior to urological surgery.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
